Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 199

recruiting
3 982
countries
28
conditions
2 106

2 729 trials match your criteria

Wheezing

Not recruiting

Study on the Effectiveness and Safety of OM-85 for Children Aged 6 Months to 5 Years with Recurrent Wheezing

Registered drug
Countries:PolandPoland
  • Participants:0–17 years

Neoplasm

Not recruiting

Study on Cetrelimab for Patients with Advanced Cancers

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab

Colon cancer+5

Not recruiting

Study on Selpercatinib for Adults with Advanced or Metastatic Solid Tumors with RET Activation

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Selpercatinib

Study on the Safety and Effectiveness of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177LU) vipivotide tetraxetan

Study on the Safety and Effectiveness of ABSK021 for Patients with Tenosynovial Giant Cell Tumor

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ABSK021 hydrochloride hydrate

Plasma cell myeloma

Not recruiting

Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide

Open angle glaucoma

Not recruiting

Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bimatoprost
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Secukinumab
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine

Dermatitis atopic

Not recruiting

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Upadacitinib

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban

Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tacrolimus
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.